Lyfegen is an independent provider of rebate management software designed for the healthcare industry.
Lyfegen’s solutions are used by insurers, government bodies, payers, and pharmaceutical companies around
the globe to dramatically reduce the administrative burden of managing complex drug pricing agreements
and to optimize rebates and get better value from those agreements.
Lyfegen maintains the world’s largest digital repository of innovative drug pricing models and public
agreements and offers access to a robust drug pricing simulator designed to dynamically simulate complex
drug pricing scenarios to understand the full financial impact. Headquartered in Basel, Switzerland, the
company was founded in 2018 and has market presence in Europe, North America, and the Middle East.
Learn more at Lyfegen.com